Jaishri Blakeley
@jblakel3
Marjorie Bloomberg Tiven Professor of Neurofibromatosis; Johns Hopkins University
ID: 4841511857
24-01-2016 10:16:26
673 Tweet
216 Followers
324 Following
Lucky to have amazing colleagues and collaborators like NCI Center for Cancer Research-NCI Center for Cancer Research’s Dr. Xiyuan Zhang who presented amazing work using scRNAseq data to inform and improve clinical care! Children's Tumor Fdn #CTF2024 #endNF
Happy 4th of July - to celebrate, we asked if there is meaningful heterogeneity within somatic NF1 mutant glioblastomas? We think so biorxiv.org/content/10.110… As always, appreciate everyone that made this work possible UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr Neurofibromatosis Therapeutic Acceleration Program Children's Tumor Fdn
Hello X-verse! At Sage Bionetworks we're hiring for a bunch of new roles. Do you care about health & bio data to actually translate into patient benefit? Apply here: 👇 sagebionetworks.org/careers Please RT and help me spread the word!
Today Mike Bloomberg spoke about our $600 million gift to Howard University School of Medicine, Morehouse School of Medicine, Meharry Medical College, & @CDrewU to grow their endowments and help strengthen their financial stability. bloombg.org/4fyWbwz
#NF researchers, are you ready for Neurofibromatosis Young Investigators Forum this Dec? We've partnered with CEC Oncology to help you showcase your research, connect with other Young Investigators, & catalyze your career. Submit your abstract! ➡️ ce.ceconcepts.com/NFYIFsubmit #NF #EndNF #MedTwitter #MedEd
Congrats! Proud to support Soragni:Lab! The lack of therapies for #cNF stems from the complexity of their cell composition. Dr. Soragni & team developed a high-throughput organoid screening platform that rapidly tests 3D tumor organoids for drug efficacy. Great work! #NF1
Thrilled that our long-term partner SpringWorks has received FDA Priority Review for mirdametinib, a potential treatment for NF1 children and adults. We are dedicated to deploying time, talent and funding towards accelerating the development of new treatments for NF! #EndNF
Excellent work @klemberg. Important prognostic data and insight into impact of neurofibromas. Thank you for making this work happen. #NF1 NCI CCR Pediatric Oncology Branch Johns Hopkins Children's Center Johns Hopkins Kimmel Cancer Center
New in Small Molecule Therapeutics from the September issue—MEK Inhibition Enhances the Antitumor Effect of #Radiotherapy in #NF1-Deficient #Glioblastoma. bit.ly/3XmdHMf Maria Ioannou Dr. Schreck Abiola Christine Pratilas MD Johns Hopkins Kimmel Cancer Center Johns Hopkins Neurosurgery